326 related articles for article (PubMed ID: 34220852)
21. [A comparison of clinical characteristics and prognosis of adult acute graft-versus-host disease between human leukocyte antigen- identical and -mismatched allogeneic hematopoietic stem cell transplantation].
Zhao X; Xu L; Liu D; Han T; Wang Y; Zhang X; Yan C; Chen H; Han W; Wang J; Zhao T; Li Y; Zhang B; Zhao X; Liu K; Huang X
Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):35-9. PubMed ID: 24674726
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
Meng XJ; Lin MF; Cai Z
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
Shono Y; van den Brink MRM
Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
[TBL] [Abstract][Full Text] [Related]
24. Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Faraci M; Bonaretti C; Dell'Orso G; Pierri F; Giardino S; Angiero F; Blasi S; Farronato G; Di Marco E; Trevisiol A; Olcese E; Rufino L; Squillario M; Biassoni R
Sci Rep; 2024 Mar; 14(1):6708. PubMed ID: 38509104
[TBL] [Abstract][Full Text] [Related]
25. An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantation.
Bueno F; Albert E; Giménez E; Piñana JL; Pérez A; Dolores Gómez M; Hernández-Boluda JC; Gonzalez-Barberá EM; Montoro J; Buesa J; Guerreiro M; Balaguer-Roselló A; Hernani R; Sanz J; Solano C; Navarro D
J Med Virol; 2021 Aug; 93(8):4773-4779. PubMed ID: 33605457
[TBL] [Abstract][Full Text] [Related]
26. Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Chen YB; Shah NN; Renteria AS; Cutler C; Jansson J; Akbari M; Chen C; Quadri S; Parfionovas A; Devine SM
Blood Adv; 2019 Dec; 3(23):4136-4146. PubMed ID: 31821456
[TBL] [Abstract][Full Text] [Related]
27. The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
Wang S; Yue X; Zhou H; Chen X; Chen H; Hu L; Pan W; Zhao X; Xiao H
Ann Hematol; 2023 Dec; 102(12):3555-3566. PubMed ID: 37770617
[TBL] [Abstract][Full Text] [Related]
28. [Clinical characteristics of acute graft-versus-host disease confined solely to gastrointestinal tract after allogeneic hematopoietic stem cell transplantation].
Feng R; Liu DH; Xu LP; Chen H; Zhang XH; Han W; Zhao T; Liu KY; Huang XJ
Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1028-31. PubMed ID: 21211361
[TBL] [Abstract][Full Text] [Related]
29. Ceruloplasmin is a potential biomarker for aGvHD following allogeneic hematopoietic stem cell transplantation.
Lv M; Ye HG; Zhao XS; Zhao XY; Chang YJ; Liu DH; Xu LP; Huang XJ
PLoS One; 2013; 8(3):e58735. PubMed ID: 23505556
[TBL] [Abstract][Full Text] [Related]
30. Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
Han L; Zhang H; Chen S; Zhou L; Li Y; Zhao K; Huang F; Fan Z; Xuan L; Zhang X; Dai M; Lin Q; Jiang Z; Peng J; Jin H; Liu Q
Biol Blood Marrow Transplant; 2019 Oct; 25(10):1944-1955. PubMed ID: 31299215
[TBL] [Abstract][Full Text] [Related]
31. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
Parco S; Benericetti G; Vascotto F; Palmisciano G
Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
[TBL] [Abstract][Full Text] [Related]
32. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
33. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
34. Prolonged gut microbial alterations in post-transplant survivors of allogeneic haematopoietic stem cell transplantation.
Hino A; Fukushima K; Kusakabe S; Ueda T; Sudo T; Fujita J; Motooka D; Takeda AK; Shinozaki NO; Watanabe S; Yokota T; Shibayama H; Nakamura S; Hosen N
Br J Haematol; 2023 May; 201(4):725-737. PubMed ID: 36468273
[TBL] [Abstract][Full Text] [Related]
35. Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance.
Hong T; Wang R; Wang X; Yang S; Wang W; Gao Q; Zhang X
Front Immunol; 2021; 12():644982. PubMed ID: 33815399
[TBL] [Abstract][Full Text] [Related]
36. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease.
Burgos da Silva M; Ponce DM; Dai A; M Devlin S; Gomes ALC; Moore G; Slingerland J; Shouval R; Armijo GK; DeWolf S; Fei T; Clurman A; Fontana E; Amoretti LA; Wright RJ; Andrlova H; Miltiadous O; Perales MA; Taur Y; Peled JU; van den Brink MRM
Blood; 2022 Dec; 140(22):2385-2397. PubMed ID: 35969834
[TBL] [Abstract][Full Text] [Related]
37. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide.
Greco R; Lorentino F; Nitti R; Lupo Stanghellini MT; Giglio F; Clerici D; Xue E; Lazzari L; Piemontese S; Mastaglio S; Assanelli A; Marktel S; Corti C; Bernardi M; Ciceri F; Peccatori J
Front Immunol; 2019; 10():2319. PubMed ID: 31632401
[No Abstract] [Full Text] [Related]
39. Expressions of tissue factor and tissue factor pathway inhibitor in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Hao J; Li W; Zou P; Li Q; Xia L; You Y
J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):697-700. PubMed ID: 20037809
[TBL] [Abstract][Full Text] [Related]
40. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
